"Heroin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed)
| Descriptor ID |
D003932
|
| MeSH Number(s) |
D03.132.577.249.562.445 D03.605.497.607.490 D03.633.400.686.607.490 D04.615.723.795.576.445
|
| Concept/Terms |
Heroin- Heroin
- Diacetylmorphine
- Diamorphine
Heroin Hydrochloride- Heroin Hydrochloride
- Hydrochloride, Heroin
- Diacetylmorphine Hydrochloride
- Hydrochloride, Diacetylmorphine
|
Below are MeSH descriptors whose meaning is more general than "Heroin".
Below are MeSH descriptors whose meaning is more specific than "Heroin".
This graph shows the total number of publications written about "Heroin" by people in this website by year, and whether "Heroin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heroin" by people in Profiles.
-
Benau EM, Zavodnick JH, Jaffe RC. Initial evidence of reliability and validity of an implicit association test assessing attitudes toward individuals who use substances. Am J Drug Alcohol Abuse. 2024 01 02; 50(1):64-74.
-
D'Orazio J, Nelson L, Perrone J, Wightman R, Haroz R. Xylazine Adulteration of the Heroin-Fentanyl Drug Supply : A Narrative Review. Ann Intern Med. 2023 10; 176(10):1370-1376.
-
Carlier J, La Maida N, Di Trana A, Huestis MA, Pichini S, Busard? FP. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids. Ther Drug Monit. 2020 04; 42(2):205-221.
-
Voelker J, Maio V, Mammen P. Changing the Narrative: Refocusing the Efforts of Emergency Departments in the Opioid Epidemic. Am J Med Qual. 2018 07; 33(4):345-347.
-
Eriksen GS, Andersen JM, Boix F, Bergh MS, Vindenes V, Rice KC, Huestis MA, M?rland J. Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice. J Pharmacol Exp Ther. 2016 08; 358(2):209-15.
-
Brunet BR, Barnes AJ, Scheidweiler KB, Mura P, Huestis MA. Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Anal Bioanal Chem. 2008 Sep; 392(1-2):115-27.
-
Dams R, Choo RE, Lambert WE, Jones H, Huestis MA. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug Alcohol Depend. 2007 Mar 16; 87(2-3):258-67.
-
Selbst SM. Pediatric emergency medicine: legal briefs. Pediatr Emerg Care. 2005 Sep; 21(9):633-6.
-
Ward SJ, Morgan D, Roberts DC. Comparison of the reinforcing effects of cocaine and cocaine/heroin combinations under progressive ratio and choice schedules in rats. Neuropsychopharmacology. 2005 Feb; 30(2):286-95.
-
Dams R, Murphy CM, Lambert WE, Huestis MA. Urine drug testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2003; 17(14):1665-70.